XML 154 R34.htm IDEA: XBRL DOCUMENT v3.25.2
VARIABLE INTEREST ENTITY (Tables)
3 Months Ended 12 Months Ended
Mar. 31, 2025
Dec. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
SCHEDULE OF CONSOLIDATED FINANCIAL STATEMENTS OF VARIABLE INTEREST ENTITY

 SCHEDULE OF CONSOLIDATED FINANCIAL STATEMENTS OF VARIABLE INTEREST ENTITY

   March 31,
2025
   December 31,
2024
 
ASSETS          
Current assets          
Cash and cash equivalents  $30,935   $41,247 
Accounts receivable   26,768    20,076 
Prepaid expenses and other current assets   21,662    32,493 
Total Current Assets   79,365    93,816 
           
Property and equipment, net   1,799,372    1,799,372 
Loans receivables from subsidiaries of the Company   3,142,552    3,122,157 
Other assets   2,275    2,275 
Total Non-current Assets   4,944,199    4,923,804 
           
Total Assets  $5,023,564   $5,017,620 
           
LIABILITIES          
Current Liabilities          
Accounts payable  $18,450   $18,904 
Accrued liabilities and other current liabilities   17,824    17,824 
Due to related party   2,780,966    2,797,018 
Total Current Liabilities   2,817,240    2,833,746 
           
Loan payable to a subsidiary of the Company   8,256,774    8,245,328 
Total Non-current Liabilities   8,256,774    8,245,328 
           
Total Liabilities  $11,074,014   $11,079,074 

 

   2025   2024 
   For the Three Months Ended
March 31,
 
   2025   2024 
Revenues  $40,470   $148,390 
Cost of revenues  $   $56,510 
Total operating expenses  $47,800   $142,801 
Net income (loss)  $17,671   $(50,921)
Net cash provided by (used in) operating activities  $(3,644)  $20,603 
Net cash provided by (used in) investing activities  $25,000   $(5,000)
Net cash used in financing activities  $(16,052)  $(9,873)

 

   2024   2023 
   As of December 31, 
   2024   2023 
ASSETS          
Current assets          
Cash and cash equivalents  $41,247   $28,934 
Accounts receivable   20,076    26,916 
Prepaid expenses and other current assets   32,493    11,074 
Total Current Assets   93,816    66,924 
           
Property and equipment, net   1,799,372    1,799,372 
Loans receivable from subsidiaries of the Company   3,122,157    3,060,581 
Other assets   2,275    2,275 
Total Non-Current Assets   4,923,804    4,862,228 
           
Total Assets  $5,017,620   $4,929,152 
           
LIABILITIES          
Current Liabilities          
Accounts payable  $18,904   $17,942 
Accrued liabilities and other current liabilities   17,824    17,824 
Due to related party   2,797,018    2,875,408 
Total Current Liabilities   2,833,746    2,911,174 
           
Loan payable to a subsidiary of the Company   8,245,328    9,157,660 
Total Non-current Liabilities   8,245,328    9,157,660 
           
Total Liabilities  $11,079,074   $12,068,834 

 

 

SBC MEDICAL GROUP HOLDINGS INCORPORATED

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 3 — VARIABLE INTEREST ENTITY (cont.)

 

   2024   2023 
  

For the Years Ended

December 31,

 
   2024   2023 
Revenues  $269,800   $163,146 
Cost of revenues  $56,510   $61,647 
Total operating expenses  $402,397   $128,549 
Net loss  $(47,782)  $(27,050)
Net cash provided by (used in) operating activities  $(182,991)  $202,624 
Net cash provided by (used in) investing activities  $195,000   $(90,000)
Net cash used in financing activities  $(78,390)  $(158,714)